Leakage kinetics of the liposomal chemotherapeutic agent Doxil: The role of dissolution, protonation, and passive transport, and implications for mechanism of action-Reference-Cited by-同舟云学术

Leakage kinetics of the liposomal chemotherapeutic agent Doxil: The role of dissolution, protonation, and passive transport, and implications for mechanism of action

Published:2018-01 Issue: Volume:269 Page:171-176
ISSN:0168-3659
Container-title:Journal of Controlled Release
language:en
Short-container-title:Journal of Controlled Release

Author:

Russell Luisa M.,Hultz Margot,Searson Peter C.^ORCID

Funder

DTRA

NIH

Publisher

Elsevier BV

Subject

Pharmaceutical Science

Reference21 articles.

1. Pharmacokinetics of pegylated liposomal doxorubicin - review of animal and human studies;Gabizon;Clin. Pharmacokinet.,2003

2. Doxil®—the first FDA-approved nano-drug: lessons learned;Barenholz;J. Control. Release,2012

3. State-of-the-art in design rules for drug delivery platforms: lessons learned from FDA-approved nanomedicines;Dawidczyk;J. Control. Release,2014

4. Doxorubicin physical state in solution and inside liposomes loaded via a pH gradient;Li;Biochim. Biophys. Acta (BBA),1998

5. Fluorinated phosphatidylcholine-based liposomes - H+/Na+ permeability, active doxorubicin encapsulation and stability in human serum;Frezard;Biochim. Biophys. Acta,1994

Cited by 61 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. PBPK model of pegylated liposomal doxorubicin to simultaneously predict the concentration–time profile of encapsulated and free doxorubicin in tissues;Drug Delivery and Translational Research;2024-08-05

2. Nanomaterial Delivery Vehicles for the Development of Neoantigen Tumor Vaccines for Personalized Treatment;Molecules;2024-03-25

3. A Microfluidic Platform for Evaluating the Internalization of Liposome Drug Carriers in Tumor Spheroids;ACS Applied Materials & Interfaces;2024-02-15

4. Remote loading in liposome: a review of current strategies and recent developments;Journal of Liposome Research;2024-02-11

5. SiRNF8 Delivered by DNA Framework Nucleic Acid Effectively Sensitizes Chemotherapy in Colon Cancer;International Journal of Nanomedicine;2024-01